Kezar Life Sciences, Inc.
Biotechnology · Healthcare
Board Member
2015-01-01–present
Board Member
Kezar Life Sciences, Inc.
Equibles does not estimate personal net worth.
Christopher Kirk is recorded as Board Member at Kezar Life Sciences, Inc. since January 1, 2015. The newest filing on record that lists Christopher Kirk as Board Member at Kezar Life Sciences, Inc. is dated April 25, 2025. The proxy statement of Kezar Life Sciences, Inc. reports total compensation of $927,300 for Christopher Kirk in fiscal 2024, including a base salary of $600,000. Disclosed compensation is on record for 7 fiscal years. Kezar Life Sciences, Inc. is classified in the Biotechnology industry within the Healthcare sector.
Kezar Life Sciences, Inc.
Board Member
Proxy statement
2015-01-01–present
Last confirmed April 25, 2025
Kezar Life Sciences, Inc.
Source not stated
Start not stated–2023-04-21
Kezar Life Sciences, Inc.
CEO
Proxy statement
Start not stated–2026-04-01
Kezar Life Sciences, Inc.
Biotechnology · Healthcare
Board Member
2015-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Kezar Life Sciences, Inc. | Chief Executive Officer | $600,000 | $927,300 |
| 2023 | Kezar Life Sciences, Inc. | Chief Executive Officer | $242,240 | $2,602,155 |
| 2022 | Kezar Life Sciences, Inc. | Chief Executive Officer | $468,000 | $2,470,432 |
| 2021 | Kezar Life Sciences, Inc. | President and Chief Scientific Officer | $443,000 | $1,685,890 |
| 2020 | Kezar Life Sciences, Inc. | President and Chief Scientific Officer | $426,000 | $880,099 |
| 2019 | Kezar Life Sciences, Inc. | President and Chief Scientific Officer | $410,000 | $1,942,334 |
| 2018 | Kezar Life Sciences, Inc. | President and Chief Scientific Officer | $365,000 | $962,353 |
No call appearances or filed executive changes recorded yet.